Celularity Inc.'s (NASDAQ:CELU) top owners are public companies with 35% stake, while 35% is held by individual investors
Key Insights The considerable ownership by public companies in Celularity indicates that they collectively have a...
Stay updated with breaking news from Celularity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights The considerable ownership by public companies in Celularity indicates that they collectively have a...
By Will Feuer Celularity Chief Executive Robert Hariri said the biotechnology company expects to report 2023 revenue that is 23% to 27% higher than the...
Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 31,700 shares, an increase of 149.6% from the December 15th total of 12,700 shares. Based on an average daily trading volume, of 66,600 shares, […]
By Ben Glickman Celularity on Thursday confirmed that it had entered a commercialization agreement with BioCellgraft to make biomaterial products for dental...
By Ben Glickman Celularity is expecting fourth-quarter sales from its biomaterial products and biobanking businesses to nearly triple. The Florham Park,...